Robert M. Whelan,. Jr's Net Worth
$3.38 Million
Who is Robert M. Whelan,. Jr?
Robert M. Whelan,. Jr has an estimated net worth of $3.38 Million. This is based on reported shares across multiple companies, which include ASPENTECH Corp, iANTHUS CAPITAL HOLDINGS, INC., Annovis Bio, Inc., Aspen Technology, Inc., and ARIAD PHARMACEUTICALS INC.
SEC CIK
Robert M. Whelan,. Jr's CIK is 0001490045
Past Insider Trading and Trends
2022 was Robert M. Whelan,. Jr's most active year for acquiring shares with 9 total transactions. Robert M. Whelan,. Jr's most active month to acquire stocks was the month of December. 2022 was Robert M. Whelan,. Jr's most active year for disposing of shares, totalling 9 transactions. Robert M. Whelan,. Jr's most active month to dispose stocks was the month of April. 2020 saw Robert M. Whelan,. Jr paying a total of $203,644.80 for 115,700 shares, this is the most they've acquired in one year. In 2022 Robert M. Whelan,. Jr cashed out on 39,227 shares for a total of $637,890.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ASPENTECH Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.69K |
—
|
—
|
0
|
May 16
| |||
Form 4
| +6.42% | 826 |
$91.23 | -$544,136.95 | 13.69K |
May 11 - May 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iANTHUS CAPITAL HOLDINGS, INC. (ITHUF) Snapshot price: $0.0237
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Annovis Bio, Inc. (ANVS) Snapshot price: $10.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
∞
| 95.7K |
$5.63 |
—
| 95.7K |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aspen Technology, Inc. (AZPN) Snapshot price: $193.67
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.33% | 1.2K |
—
|
—
| 9.54K |
Jul 1
| |||
Form 4
|
—
|
0
|
$134.21 | -$398,709.70 | 8.34K |
May 21
| |||
Form 4/A
| +42.88% | 2.5K |
—
|
—
| 8.34K |
Sep 1
| |||
Form 4
| +42.88% | 2.5K |
—
|
—
| 8.34K |
Sep 1
| |||
Form 4
|
—
|
0
|
$100.55 | -$398,685.42 | 5.84K |
Jun 12
| |||
Form 4
| +1.57% | 90 |
—
|
—
| 5.84K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARIAD PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.63% | 12.5K |
—
|
—
| 44.86K |
Jan 31
| |||
Form 4
| +76.26% | 14K |
—
|
—
| 32.36K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
| 53.36K |
Dec 26
| |||
Form 4
| +52.45% | 18.36K |
—
|
—
| 53.36K |
Jan 31
| |||
Form 4
| +133.33% | 20K |
—
|
—
| 35K |
Jan 31
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||